Solenthaler, Max

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping

Journal Article

Colucci, Giuseppe; Silzle, Tobias; Solenthaler, Max (2012). Pyrazinamide-induced sideroblastic anemia. American journal of hematology, 87(3), p. 305. New York, N.Y.: Wiley-Liss 10.1002/ajh.2830280316

Béné, M C; Nebe, T; Bettelheim, P; Buldini, B; Bumbea, H; Kern, W; Lacombe, F; Lemez, P; Marinov, I; Matutes, E; Maynadié, M; Oelschlagel, U; Orfao, A; Schabath, R; Solenthaler, M; Tschurtschenthaler, G; Vladareanu, A M; Zini, G; Faure, G C and Porwit, A (2011). Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia, 25(4), pp. 567-74. Basingstoke: Nature Publishing Group 10.1038/leu.2010.312

Leupin, Nicolas; Schuller, Jan C; Solenthaler, Max; Heim, Dominik; Rovo, Alicia; Beretta, Kurt; Gregor, Michael; Bargetzi, Mario J; Brauchli, Peter; Himmelmann, Andreas; Hanselmann, Silvia; Zenhäusern, Reinhard (2010). Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02). Leukemia & lymphoma, 51(4), pp. 613-9. London: Informa Healthcare 10.3109/10428191003624231

Zenhäusern, R; Schmitz, S-F Hsu; Solenthaler, M; Heim, D; Meyer-Monard, S; Hess, U; Leoncini, L; Bargetzi, M; Rufener, B; Tobler, A (2009). Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leukemia & lymphoma, 50(9), pp. 1501-11. London: Informa Healthcare 10.1080/10428190903131755

Heimpel, Hermann; Dührsen, Ulrich; Hofbauer, P; Rigamonti-Wermlinger, V; Kreuser, Ernst-Dietrich; Schwarz, Klaus; Solenthaler, Max; Pauls, S (2009). Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia. Annals of hematology, 88(10), pp. 937-41. Berlin: Springer 10.1007/s00277-009-0735-5

Zenhäusern, Reinhard; Von Rohr, Albert; Rufibach, Kaspar; Solenthaler, Max; Meyer-Monard, Sandrine; Gratwohl, Alois; Hess, Urs; Bargetzi, Mario J; Kovacsovic, Tibor; Leoncini, Leda; Tobler, Andreas (2009). Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95. Leukemia & lymphoma, 50(1), pp. 133-6. London: Informa Healthcare 10.1080/10428190802527681

Mumprecht, Sabine Barbara; Schürch, Christian; Schwaller, Juerg; Solenthaler, Max; Ochsenbein, Adrian F (2009). Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood, 114(8), pp. 1528-1536. Washington, D.C.: American Society of Hematology 10.1182/blood-2008-09-179697

Larson, RA; Druker, BJ; Guillot, F; O'Brien, SG; Riviere, GJ; Krahnke, T; Gathmann, I; Wang, Y; Study Group, IRIS; Collaborator Solenthaler, M (2008). Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. Blood, 111(8), pp. 4022-8. Washington, D.C.: American Society of Hematology 10.1182/blood-2007-10-116475

Hehlmann, Rüdiger; Berger, Ute; Pfirrmann, Markus; Heimpel, Hermann; Hochhaus, Andreas; Hasford, Joerg; Kolb, Hans-Jochem; Lahaye, Tanja; Maywald, Ole; Reiter, Andreas; Hossfeld, Dieter K; Huber, Christoph; Löffler, Helmut; Pralle, Hans; Queisser, Wolfgang; Tobler, Andreas; Nerl, Christoph; Solenthaler, Max; Goebeler, Mariele E; Griesshammer, Martin; ... (2007). Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Blood, 109(11), pp. 4686-92. Washington, D.C.: American Society of Hematology 10.1182/blood-2006-11-055186

Meier, N; Lipp, E; Solenthaler, M (2007). [Pancytopenia and hemolysis--diagnosis, differential diagnosis and therapy of pernicious anemia]. Deutsche medizinische Wochenschrift, 132(27), pp. 1469-74. Stuttgart: Thieme 10.1055/s-2007-982055

Schmidt, A; Solenthaler, M (2007). Chronische lymphatische Leukämie: Einteilung, Verlauf, Therapie und Prognose der CLL. Onkologie(1), pp. 20-9. Basel: Karger

Mueller, B U; Buerger, A U; Solenthaler, M; Garamvoelgyi, E M; Oppliger-Leibundgut, E; Fey, M F; Pabst, T (2006). Pleural tumors as sole primary manifestation of acute promyelocytic leukemia. Annals of oncology, 17(4), pp. 722-3. Oxford: Oxford University Press 10.1093/annonc/mdj062

Provide Feedback